Copyright Reports & Markets. All rights reserved.

Global Percutaneous Ventricular Assist Device Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Percutaneous Ventricular Assist Device
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Percutaneous Ventricular Assist Device Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Impella CP
    • 1.3.3 Impella 5.1
    • 1.3.4 Impella LD
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Percutaneous Ventricular Assist Device Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Heart Failure
    • 1.4.3 Myocardial Infarction
    • 1.4.4 Other
  • 1.5 Global Percutaneous Ventricular Assist Device Market Size & Forecast
    • 1.5.1 Global Percutaneous Ventricular Assist Device Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Percutaneous Ventricular Assist Device Sales Quantity (2018-2029)
    • 1.5.3 Global Percutaneous Ventricular Assist Device Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Percutaneous Ventricular Assist Device Product and Services
    • 2.1.4 Johnson & Johnson Percutaneous Ventricular Assist Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Johnson & Johnson Recent Developments/Updates

3 Competitive Environment: Percutaneous Ventricular Assist Device by Manufacturer

  • 3.1 Global Percutaneous Ventricular Assist Device Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Percutaneous Ventricular Assist Device Revenue by Manufacturer (2018-2023)
  • 3.3 Global Percutaneous Ventricular Assist Device Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Percutaneous Ventricular Assist Device by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Percutaneous Ventricular Assist Device Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Percutaneous Ventricular Assist Device Manufacturer Market Share in 2022
  • 3.5 Percutaneous Ventricular Assist Device Market: Overall Company Footprint Analysis
    • 3.5.1 Percutaneous Ventricular Assist Device Market: Region Footprint
    • 3.5.2 Percutaneous Ventricular Assist Device Market: Company Product Type Footprint
    • 3.5.3 Percutaneous Ventricular Assist Device Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Percutaneous Ventricular Assist Device Market Size by Region
    • 4.1.1 Global Percutaneous Ventricular Assist Device Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Percutaneous Ventricular Assist Device Consumption Value by Region (2018-2029)
    • 4.1.3 Global Percutaneous Ventricular Assist Device Average Price by Region (2018-2029)
  • 4.2 North America Percutaneous Ventricular Assist Device Consumption Value (2018-2029)
  • 4.3 Europe Percutaneous Ventricular Assist Device Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Percutaneous Ventricular Assist Device Consumption Value (2018-2029)
  • 4.5 South America Percutaneous Ventricular Assist Device Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Percutaneous Ventricular Assist Device Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Percutaneous Ventricular Assist Device Sales Quantity by Type (2018-2029)
  • 5.2 Global Percutaneous Ventricular Assist Device Consumption Value by Type (2018-2029)
  • 5.3 Global Percutaneous Ventricular Assist Device Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Percutaneous Ventricular Assist Device Sales Quantity by Application (2018-2029)
  • 6.2 Global Percutaneous Ventricular Assist Device Consumption Value by Application (2018-2029)
  • 6.3 Global Percutaneous Ventricular Assist Device Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Percutaneous Ventricular Assist Device Sales Quantity by Type (2018-2029)
  • 7.2 North America Percutaneous Ventricular Assist Device Sales Quantity by Application (2018-2029)
  • 7.3 North America Percutaneous Ventricular Assist Device Market Size by Country
    • 7.3.1 North America Percutaneous Ventricular Assist Device Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Percutaneous Ventricular Assist Device Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Percutaneous Ventricular Assist Device Sales Quantity by Type (2018-2029)
  • 8.2 Europe Percutaneous Ventricular Assist Device Sales Quantity by Application (2018-2029)
  • 8.3 Europe Percutaneous Ventricular Assist Device Market Size by Country
    • 8.3.1 Europe Percutaneous Ventricular Assist Device Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Percutaneous Ventricular Assist Device Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Percutaneous Ventricular Assist Device Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Percutaneous Ventricular Assist Device Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Percutaneous Ventricular Assist Device Market Size by Region
    • 9.3.1 Asia-Pacific Percutaneous Ventricular Assist Device Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Percutaneous Ventricular Assist Device Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Percutaneous Ventricular Assist Device Sales Quantity by Type (2018-2029)
  • 10.2 South America Percutaneous Ventricular Assist Device Sales Quantity by Application (2018-2029)
  • 10.3 South America Percutaneous Ventricular Assist Device Market Size by Country
    • 10.3.1 South America Percutaneous Ventricular Assist Device Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Percutaneous Ventricular Assist Device Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Percutaneous Ventricular Assist Device Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Percutaneous Ventricular Assist Device Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Percutaneous Ventricular Assist Device Market Size by Country
    • 11.3.1 Middle East & Africa Percutaneous Ventricular Assist Device Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Percutaneous Ventricular Assist Device Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Percutaneous Ventricular Assist Device Market Drivers
  • 12.2 Percutaneous Ventricular Assist Device Market Restraints
  • 12.3 Percutaneous Ventricular Assist Device Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Percutaneous Ventricular Assist Device and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Percutaneous Ventricular Assist Device
  • 13.3 Percutaneous Ventricular Assist Device Production Process
  • 13.4 Percutaneous Ventricular Assist Device Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Percutaneous Ventricular Assist Device Typical Distributors
  • 14.3 Percutaneous Ventricular Assist Device Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Percutaneous Ventricular Assist Device market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    The Global Info Research report includes an overview of the development of the Percutaneous Ventricular Assist Device industry chain, the market status of Heart Failure (Impella CP, Impella 5.1), Myocardial Infarction (Impella CP, Impella 5.1), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Percutaneous Ventricular Assist Device.
    Regionally, the report analyzes the Percutaneous Ventricular Assist Device markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Percutaneous Ventricular Assist Device market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Percutaneous Ventricular Assist Device market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Percutaneous Ventricular Assist Device industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Impella CP, Impella 5.1).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Percutaneous Ventricular Assist Device market.
    Regional Analysis: The report involves examining the Percutaneous Ventricular Assist Device market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Percutaneous Ventricular Assist Device market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Percutaneous Ventricular Assist Device:
    Company Analysis: Report covers individual Percutaneous Ventricular Assist Device manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Percutaneous Ventricular Assist Device This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Heart Failure, Myocardial Infarction).
    Technology Analysis: Report covers specific technologies relevant to Percutaneous Ventricular Assist Device. It assesses the current state, advancements, and potential future developments in Percutaneous Ventricular Assist Device areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Percutaneous Ventricular Assist Device market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Percutaneous Ventricular Assist Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Impella CP
    Impella 5.1
    Impella LD
    Market segment by Application
    Heart Failure
    Myocardial Infarction
    Other
    Major players covered
    Johnson & Johnson
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Percutaneous Ventricular Assist Device product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Percutaneous Ventricular Assist Device, with price, sales, revenue and global market share of Percutaneous Ventricular Assist Device from 2018 to 2023.
    Chapter 3, the Percutaneous Ventricular Assist Device competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Percutaneous Ventricular Assist Device breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Percutaneous Ventricular Assist Device market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Percutaneous Ventricular Assist Device.
    Chapter 14 and 15, to describe Percutaneous Ventricular Assist Device sales channel, distributors, customers, research findings and conclusion.

    Buy now